Back to Home

Integrated Medical Procedures: A Large RegenMed Market Opportunity

February 18, 2025

Share This Page
Facebook Logo
Twitter Logo
Linkedin Logo
Email Icon
View as PDF

Integrated Medical Procedures: A Large RegenMed Market Opportunity

June 9, 2025

THIS CAMPAIGN IS ENDING EARLY ON MARCH 6

‍The Large and Growing Market

Healthcare is undergoing a paradigm shift.  With rising chronic diseases, escalating healthcare costs, and growing dissatisfaction with conventional treatments, patients are turning to Complementary and Alternative Medicine (CAM).  

CAM is no longer seen as fringe medicine.  It is now a mainstream movement, with increasing adoption in hospitals, clinics, and even corporate wellness programs.  Over 50% of U.S. physicians recommended at least one complementary health approach to their patients within a 12-month period. 1

One-third of Americans use CAM alongside conventional treatments.  In Europe, 25-50% of the population uses CAM therapies, including homeopathy, naturopathy, and herbal medicine.  In Asia, Traditional Chinese Medicine (TCM) and Ayurveda are deeply embedded in cultural and medical systems. 2

The Global CAM Market is valued at $100–$400 billion, with a projected growth rate of 15–25%.  The U.S. CAM market is valued at over $50 billion 3.  Factors driving this growth include:

  • Patients are more proactive about their health.
  • More people are seeking alternative solutions for pain, inflammation, and metabolic disorders.
  • CAM aligns with the booming self-care, fitness, and mental health movements.
  • AI-powered health platforms, wearable biofeedback devices, and personalized wellness programs are making CAM more accessible.
  • Major corporations, insurance providers, and even governments are beginning to integrate CAM into healthcare policies and benefits. 4

True healthcare innovation lies in integration — combining the best of conventional medicine with evidence-based CAM therapies.

  • Chronic Disease Management: CAM therapies like acupuncture, herbal medicine, and functional nutrition help manage diabetes, cardiovascular diseases, and autoimmune disorders without heavy reliance on pharmaceuticals.
  • Pain & Opioid Crisis Solutions: Chiropractic care, acupuncture, and red light therapy offer non-drug alternatives for pain management, reducing opioid dependence.
  • Mental Health & Stress Reduction: Meditation, breathwork, and biofeedback therapies help treat anxiety, depression, PTSD, and insomnia — often as effectively as medication.
  • Personalized & Preventive Healthcare: Functional and integrative medicine focus on root causes rather than symptom suppression, reducing long-term healthcare costs.
  • Patient Demand & Market Trends: Hospitals and clinics adopting CAM see higher patient satisfaction, improved treatment outcomes, and increased revenue. 5

Several world-renowned institutions, such as Mayo Clinic, Cleveland Clinic, and Johns Hopkins, have already integrated CAM into their healthcare offerings—proving that a blended approach is the future of medicine.

RegenMed Is Strongly Positioned To Benefit

There is very little data on integrative, complementary, or alternative medicine procedures.  Circles represent a clinical grade yet low-cost approach to generating statistically significant datasets for any individual or combination of procedures.  RegenMed is already working with doctors around the world in developing such datasets.  They will be critical to:

  • Regulation & Standardization: Governments are creating guidelines to ensure CAM therapies meet safety and efficacy standards.
  • Insurance Expansion: More insurance companies are covering CAM services, recognizing their cost-effectiveness.
  • AI & Digital CAM Platforms: Personalized health recommendations using AI-driven diagnostics.
  • Mainstream Adoption of Holistic Wellness: Corporations are investing in employee wellness programs that integrate CAM.
  • Psychedelic-Assisted Therapy: Psilocybin and MDMA treatments are gaining momentum for mental health breakthroughs.

THIS CAMPAIGN IS ENDING EARLY ON MARCH 6

 

⇒ LAST INVESTORS WEBINAR: FEBRUARY 18 6:30 PM US EASTERN

REGISTER NOW
Share This Page
Facebook Logo
Twitter Logo
Linkedin Logo
Email Icon

Integrated Medical Procedures: A Large RegenMed Market Opportunity

February 18, 2025

THIS CAMPAIGN IS ENDING EARLY ON MARCH 6

‍The Large and Growing Market

Healthcare is undergoing a paradigm shift.  With rising chronic diseases, escalating healthcare costs, and growing dissatisfaction with conventional treatments, patients are turning to Complementary and Alternative Medicine (CAM).  

CAM is no longer seen as fringe medicine.  It is now a mainstream movement, with increasing adoption in hospitals, clinics, and even corporate wellness programs.  Over 50% of U.S. physicians recommended at least one complementary health approach to their patients within a 12-month period. 1

One-third of Americans use CAM alongside conventional treatments.  In Europe, 25-50% of the population uses CAM therapies, including homeopathy, naturopathy, and herbal medicine.  In Asia, Traditional Chinese Medicine (TCM) and Ayurveda are deeply embedded in cultural and medical systems. 2

The Global CAM Market is valued at $100–$400 billion, with a projected growth rate of 15–25%.  The U.S. CAM market is valued at over $50 billion 3.  Factors driving this growth include:

  • Patients are more proactive about their health.
  • More people are seeking alternative solutions for pain, inflammation, and metabolic disorders.
  • CAM aligns with the booming self-care, fitness, and mental health movements.
  • AI-powered health platforms, wearable biofeedback devices, and personalized wellness programs are making CAM more accessible.
  • Major corporations, insurance providers, and even governments are beginning to integrate CAM into healthcare policies and benefits. 4

True healthcare innovation lies in integration — combining the best of conventional medicine with evidence-based CAM therapies.

  • Chronic Disease Management: CAM therapies like acupuncture, herbal medicine, and functional nutrition help manage diabetes, cardiovascular diseases, and autoimmune disorders without heavy reliance on pharmaceuticals.
  • Pain & Opioid Crisis Solutions: Chiropractic care, acupuncture, and red light therapy offer non-drug alternatives for pain management, reducing opioid dependence.
  • Mental Health & Stress Reduction: Meditation, breathwork, and biofeedback therapies help treat anxiety, depression, PTSD, and insomnia — often as effectively as medication.
  • Personalized & Preventive Healthcare: Functional and integrative medicine focus on root causes rather than symptom suppression, reducing long-term healthcare costs.
  • Patient Demand & Market Trends: Hospitals and clinics adopting CAM see higher patient satisfaction, improved treatment outcomes, and increased revenue. 5

Several world-renowned institutions, such as Mayo Clinic, Cleveland Clinic, and Johns Hopkins, have already integrated CAM into their healthcare offerings—proving that a blended approach is the future of medicine.

RegenMed Is Strongly Positioned To Benefit

There is very little data on integrative, complementary, or alternative medicine procedures.  Circles represent a clinical grade yet low-cost approach to generating statistically significant datasets for any individual or combination of procedures.  RegenMed is already working with doctors around the world in developing such datasets.  They will be critical to:

  • Regulation & Standardization: Governments are creating guidelines to ensure CAM therapies meet safety and efficacy standards.
  • Insurance Expansion: More insurance companies are covering CAM services, recognizing their cost-effectiveness.
  • AI & Digital CAM Platforms: Personalized health recommendations using AI-driven diagnostics.
  • Mainstream Adoption of Holistic Wellness: Corporations are investing in employee wellness programs that integrate CAM.
  • Psychedelic-Assisted Therapy: Psilocybin and MDMA treatments are gaining momentum for mental health breakthroughs.

THIS CAMPAIGN IS ENDING EARLY ON MARCH 6

 

⇒ LAST INVESTORS WEBINAR: FEBRUARY 18 6:30 PM US EASTERN

REGISTER NOW

‍This Reg CF offering is made available through StartEngine Primary LLC, member FINRA/SIPC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.


‍

1 Analysis of Data Gives Insight Into Complementary Health Recommendations From U.S. Physicians

2 WHO global report on traditional and complementary medicine 2019

3 Complementary And Alternative Medicine Market Size, Share & Trends Analysis Report. Complementary and Alternative Medicine Market Size, Share, and Trends 2025 to 2034

4 Statistics on Complementary and Integrative Health Approaches

5 WHO global report on traditional and complementary medicine 2019. Statistics on Complementary and Integrative Health Approaches.

Share This Page
Facebook Logo
Twitter Logo
Linkedin Logo
Email Icon

Read The Latest

June 26, 2025

Invest in the Future: Webinar with Our CEO and Co-Founder

Discover the incredible growth potential of our company! Join our CEO and Co-Founder for insights into our $100B market opportunity, ongoing market traction, and future projections.

June 4, 2025

Advantages Of Circles Over "Big Data" RWE

Discover how Circles transform Big Data RWE by providing transparent, high-integrity insights directly from trusted sources. Say goodbye to fragmented, costly data and unlock meaningful, clinically relevant information while empowering physicians.

June 3, 2025

Peptides In Modern Medicine: Establishing Safety and Efficacy

Peptides are revolutionizing clinical diagnosis and treatment with their high selectivity and favorable side effect profiles. Here are some key insights:

RegenMed LLC Logo
Scroll Up Arrow

Equity crowdfunding investments in private placements, and start-up investments in particular, are speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investment through equity crowdfunding tend to be in earlier stages of development and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Further, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and/or liquidity concerns.

Forward looking statements were included here that the Company believes to be accurate given the current information. They involve known and unknown risks, uncertainties and other important factors which if changed may affect the outcome(s).

DealMaker Securities LLC, a registered broker-dealer, and member of FINRA | SIPC, located at 4000 Eagle Point Corporate Drive, Suite 950, Birmingham, AL 35242., is the Intermediary for this offering and is not an affiliate of or connected with the Issuer.  Please check our background on FINRA's BrokerCheck.
DealMaker Securities LLC does not make investment recommendations.
DealMaker Securities LLC is NOT placing or selling these securities on behalf of the Issuer.
DealMaker Securities LLC is NOT soliciting this investment or making any recommendations by collecting, reviewing, and processing an Investor's documentation for this investment.
DealMaker Securities LLC conducts Anti-Money Laundering, Identity and Bad Actor Disqualification reviews of the Issuer, and confirms they are a registered business in good standing.
DealMaker Securities LLC is NOT vetting or approving the information provided by the Issuer or the Issuer itself.

Contact information is provided for Investors to make inquiries and requests to DealMaker Securities LLC regarding Regulation CF in general, or the status of such investor’s submitted documentation, specifically. DealMaker Securities LLC may direct Investors to specific sections of the Offering Circular to locate information or answers to their inquiry but does not opine or provide guidance on issuer related matters.

Copyright © 2025. RegenMed, Inc. All rights reserved.